Cargando…

Yttrium-90 Radioembolization in Patients with Hepatocellular Carcinoma Who have Previously Received Sorafenib

Purpose: Yttrium-90 radioembolization (RE) is a locoregional therapy option for hepatocellular carcinoma (HCC). Sorafenib is a multikinase inhibitor used in HCC that can potentially affect the efficacy of RE by altering tumor vascularity or suppressing post-irradiation angiogenesis. The safety and e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Rana, Nitesh, Ju, Andrew Wenhua, Bazylewicz, Michael, Kallakury, Bhaskar, He, Aiwu Ruth, Unger, Keith R., Lee, Justin S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2013
Materias:	Oncology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3874555/ https://www.ncbi.nlm.nih.gov/pubmed/24416722 http://dx.doi.org/10.3389/fonc.2013.00323

Ejemplares similares

Side Effects of Yttrium-90 Radioembolization
por: Riaz, Ahsun, et al.
Publicado: (2014)

Survival Outcomes for Yttrium-90 Transarterial Radioembolization With and Without Sorafenib for Unresectable Hepatocellular Carcinoma Patients
por: Teyateeti, Ajalaya, et al.
Publicado: (2020)

Yttrium-90 radioembolization for advanced inoperable hepatocellular carcinoma
por: Lee, Victor Ho-Fun, et al.
Publicado: (2015)

Transarterial Radioembolization with Yttrium-90 for the Treatment of Hepatocellular Carcinoma
por: Kallini, Joseph Ralph, et al.
Publicado: (2016)

Internal dosimetry for radioembolization therapy with Yttrium‐90 microspheres
por: Fallahpoor, Maryam, et al.
Publicado: (2017)

History and Evolution of Yttrium-90 Radioembolization for Hepatocellular Carcinoma
por: Saini, Aman, et al.
Publicado: (2019)

Role of Yttrium-90 Radioembolization for Colorectal Hepatic Metastasis
por: Kim, Hyo-Cheol
Publicado: (2022)

Yttrium-90 Radioembolization as the Major Treatment of Hepatocellular Carcinoma
por: Yu, Chun-Yen, et al.
Publicado: (2023)

Yttrium-90 Radioembolization of Hepatic Metastases from Colorectal Cancer
por: Raval, Mihir, et al.
Publicado: (2014)

Yttrium-90 Radioembolization: An Unusual Cause of Radiating Abdominal Pain
por: Estes, Derek J., et al.
Publicado: (2019)

Transarterial radioembolization with Yttrium-90: current status and future prospects
por: Yang, Hua-Yu, et al.
Publicado: (2020)

Disease control and failure patterns of unresectable hepatocellular carcinoma following transarterial radioembolization with yttrium-90 microspheres and with/without sorafenib
por: Teyateeti, Ajalaya, et al.
Publicado: (2021)

Comparison of PET/CT and PET/MR imaging and dosimetry of yttrium-90 ((90)Y) in patients with unresectable hepatic tumors who have received intra-arterial radioembolization therapy with (90)Y microspheres
por: Knešaurek, Karin, et al.
Publicado: (2018)

Incorporating Yttrium-90 trans-arterial radioembolization (TARE) in the treatment of metastatic pancreatic adenocarcioma: a single center experience
por: Kim, Alexander Y., et al.
Publicado: (2016)

Yttrium-90 Microsphere Radioembolization for Treatment of Lung Cancer Hepatic Metastases
por: Gaba, Ron C., et al.
Publicado: (2012)

Celiac Artery Stenting to Facilitate Hepatic Yttrium-90 Radioembolization Therapy
por: Chamarthy, Murthy R., et al.
Publicado: (2012)

Successful Yttrium-90 Microsphere Radioembolization for Hepatic Metastases of Prostate Cancer
por: Bunck, Alexander C., et al.
Publicado: (2017)

Highlighting Survival with Yttrium-90 Radioembolization Therapy in Unresectable Hepatocellular Carcinoma
por: Nabrinsky, Edward, et al.
Publicado: (2020)

Standardizing SPECT/CT dosimetry following radioembolization with yttrium-90 microspheres
por: Kim, S. Peter, et al.
Publicado: (2021)

Yttrium‐90 Radioembolization for the Treatment of Solitary, Unresectable HCC: The LEGACY Study
por: Salem, Riad, et al.
Publicado: (2021)

Post-radioembolization yttrium-90 PET/CT - part 1: diagnostic reporting
por: Kao, Yung-Hsiang, et al.
Publicado: (2013)

Yttrium-90 radioembolization of liver tumors: what do the images tell us?
por: Singh, Pavel, et al.
Publicado: (2014)

Advances in SPECT for Optimizing the Liver Tumors Radioembolization Using Yttrium-90 Microspheres
por: Roshan, Hoda Rezaei, et al.
Publicado: (2015)

Yttrium-90 radioembolization of unresectable hepatocellular carcinoma – a single center experience
por: Meyer, Carsten, et al.
Publicado: (2017)

Assessment of Treatment Response Following Yttrium-90 Transarterial Radioembolization of Liver Malignancies
por: Adcock, Charles S, et al.
Publicado: (2018)

Predictors of Successful Yttrium-90 Radioembolization Bridging or Downstaging in Patients with Hepatocellular Carcinoma
por: Villalobos, Alexander, et al.
Publicado: (2021)

Yttrium-90 transarterial radioembolization for liver metastases from medullary thyroid cancer
por: Puleo, Luciana, et al.
Publicado: (2022)

Radiation pneumonitis following Yttrium-90 radioembolization: A Korean multicenter study
por: Kim, Hyo-Cheol, et al.
Publicado: (2023)

Yttrium-90 transarterial radioembolization and capecitabine in hepatocellular carcinoma with portal vein involvement
por: Şener, Nur, et al.
Publicado: (2023)

Yttrium-90 Radioembolization for Colorectal Cancer Liver Metastases: A Single Institution Experience
por: Nace, Gary W., et al.
Publicado: (2011)

Case Report of Cirrhosis following Yttrium-90 Radioembolization for Pancreatic Neuroendocrine Liver Metastases
por: Loree, Jonathan M., et al.
Publicado: (2016)

Verification Study of Residual Activity Measurements After Yttrium-90 Radioembolization with Glass Microspheres
por: Ebbers, S. C., et al.
Publicado: (2020)

Yttrium-90 radioembolization for unresectable hepatic metastases of breast cancer: A systematic review
por: Feretis, Michael, et al.
Publicado: (2020)

Prognostic Factors for Overall Survival in Advanced Intrahepatic Cholangiocarcinoma Treated with Yttrium-90 Radioembolization
por: Köhler, Michael, et al.
Publicado: (2019)

Yttrium-90 radioembolization of isolated hepatic adrenocortical carcinoma metastases with negative surgical pathology
por: Lu, Sen, et al.
Publicado: (2021)

Pathologic validation of an yttrium-90 trans-arterial radioembolization dosimetry: a case report
por: Baikovitz, Jacqueline B, et al.
Publicado: (2021)

Transradial versus transfemoral arterial access in Yttrium-90 microspheres radioembolization for hepatocellular carcinoma
por: Ghosh, Abheek, et al.
Publicado: (2022)

Intrahepatic flow diversion prior to segmental Yttrium-90 radioembolization for challenging tumor vasculature
por: Young, Lindsay B., et al.
Publicado: (2022)

Yttrium-90 radioembolization for colorectal cancer liver metastases in KRAS wild-type and mutant patients: Clinical and ccfDNA studies
por: Janowski, E., et al.
Publicado: (2017)

Comparison between Y90 Radioembolization Plus Sorafenib and Y90 Radioembolization alone in the Treatment of Hepatocellular Carcinoma: A Propensity Score Analysis
por: Facciorusso, Antonio, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_gukao630866u7q5os4b7s30a8v